Edwards Lifesciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Edwards Lifesciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12% to $6,004,800,000. Profit margin reached 23%. Total operating expenses were $3,090,900,000.

Profit Margin

Edwards Lifesciences Corporation (NYSE:EW): Profit margin
2014 2.32B 811.1M 34.92%
2015 2.49B 494.9M 19.85%
2016 2.96B 569.5M 19.22%
2017 3.43B 622.1M 18.11%
2018 3.72B 722.2M 19.4%
2019 4.34B 1.04B 24.08%
2020 4.38B 823.4M 18.77%
2021 5.23B 1.50B 28.73%
2022 5.38B 1.52B 28.28%
2023 6.00B 1.40B 23.35%

EW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
6.00B5.38B5.23B4.38B4.34B3.72B3.43B2.96B2.49B2.32B
Cost of revenue
1.37B1.08B1.24B1.08B1.11B939.4M875.3M797.4M617.2M625.6M
Gross profit
4.62B4.30B3.98B3.30B3.23B2.78B2.56B2.16B1.87B1.69B
Operating exp.
Research and development
1.07B945.2M903.1M760.7M752.7M622.2M552.6M443.3M383.1M346.5M
Selling and marketing
1.2M1.1M-300K0000000
Total operating expenses
3.09B2.51B2.39B1.98B1.99B1.71B1.53B1.34B1.23B1.20B
Operating income
1.53B1.74B1.34B1.62B1.14B748.2M1.02B783.8M642.7M482.6M
Other income (expenses), net
64M18.9M353.5M19.1M19.7M-313.4M12.2M-72M-20.5M661.4M
Income before tax
1.59B1.76B1.70B916.7M1.16B761.4M1.03B737.9M622.4M1.14B
Income tax expense
198.7M245.5M198.9M93.3M119.6M39.2M412.8M168.4M127.5M332.9M
Net income
1.40B1.52B1.50B823.4M1.04B722.2M622.1M569.5M494.9M811.1M
Earnings per share
Basic EPS
2.312.462.411.321.681.150.980.890.771.27
Diluted EPS
2.32.442.381.31.641.130.960.870.751.25
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source